Hypoxia inducible factor-1α correlates with VEGF-C expression and lymphangiogenesis in breast cancer-Reference-Cited by-同舟云学术

Hypoxia inducible factor-1α correlates with VEGF-C expression and lymphangiogenesis in breast cancer

Published:2006-03-23 Issue:2 Volume:99 Page:135-141
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Schoppmann Sebastian F.,Fenzl Alexandra,Schindl Monika,Bachleitner-Hofmann Thomas,Nagy Katalin,Gnant Michael,Horvat Reinhard,Jakesz Raimund,Birner Peter

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-006-9190-3.pdf

Reference38 articles.

1. Semenza GL: HIF-1 and human disease: one highly involved factor. Genes Dev 2000; 14:1983–1991

2. Wang GL, Jiang BH, Rue EA, Semenza GL: Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995; 92:5510–5514

3. Jiang BH, Semenza GL, Bauer C, Marti HH: Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am J Physiol 1996; 271:C1172–C1180

4. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359:843–845

5. Conway EM, Collen D, Carmeliet P: Molecular mechanisms of blood vessel growth. Cardiovasc Res 2001; 49:507–521

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxia-inducible factor in breast cancer: role and target for breast cancer treatment;Frontiers in Immunology;2024-05-10

2. Lymph node metastases in breast cancer: Mechanisms and molecular imaging;Clinical Imaging;2023-11

3. Lymphangiogenesis in gastric cancer: function and mechanism;European Journal of Medical Research;2023-10-07

4. HBOT in Aging and Regeneration;Hyperbaric Oxygen Therapy: Principles and Applications;2023

5. Targeting hypoxia-inducible factors for breast cancer therapy: A narrative review;Frontiers in Pharmacology;2022-12-01